Can huge stock go on ipo

FSD Pharma Inc. (HUGE) has the potential to go public with an initial public offering (IPO). Here's why:

1. Market Interest and Recent Activity: There has been a recent surge in the IPO market, with a rally in April 2024, indicating a favorable environment for new listings. This could be a positive factor for FSD Pharma Inc. considering an IPO.
2. Company's Qualifying Characteristics: FSD Pharma Inc. operates in the biopharmaceutical sector, researching and developing treatments for various disorders. The company's lead compound is in Phase 2 clinical trials, and it also has a portfolio of strategic investments. This could align with the criteria of having a mature business with growth potential, which is often sought after for an IPO.
3. Financial and Operational Readiness: Going public requires a company to be ready with audited financials and strong business processes. FSD Pharma Inc. should be prepared with the necessary financial and operational infrastructure in place to meet the requirements of a public company.
4. Investment Banking Support: Investment banks are typically involved in the IPO process to gauge demand and set the IPO price and date. FSD Pharma Inc. would need to engage with investment banks to assess the market's appetite for its shares and determine the optimal time to list.

While the decision to go public is ultimately up to the company's management and board, the current conditions and FSD Pharma Inc.'s position within its industry suggest that it could be a viable candidate for an IPO. However, it's crucial to consider the company's specific circumstances, market conditions, and the timing of any IPO attempt.